Are we a legit contender for Marvin Johnson?

2,282 Views | 5 Replies | Last: 3 yr ago by Monkdawg
Atowndawg
How long do you want to ignore this user?
https://www.google.com/amp/s/bustingbrackets.com/2021/05/26/ncaa-basketball-analzying-final-4-teams-transfer-guard-marvin-johnson/amp/

If we got him, Tre Mitchell, and Cisse, I will have whatever Trappist Ale that Monk has been drinking.
Dawg-E-Dawg
How long do you want to ignore this user?
25%
Monkdawg
How long do you want to ignore this user?
Johnson is a new name to me. I looked at his stats a bit. He's under 30% from 3, but yeah he's a dynamic player. He's from OK, so I would bet that makes them the favorite. He would certainly be a nice addition, but Oquendo looks really good to me in his film. Beautiful jump shot, hops, very athletic. Assuming we add a big, it would mean we would have to let 2 guys go. My bet would be Ned and McMillan. But I haven't heard anything on Johnson.
Nostradawgus
How long do you want to ignore this user?
I have to believe we are out of the guard market. We have brought in three transfer shooters, a high school 2 guard, a high school PG, and transfer PG Cook.

Our biggest, most obvious, glaring hole is a big. And we all know who is targeted. And even if that happens, somebody among Ned, McMillan, or Taylor will have to exit Thunder Dome.
Monkdawg
How long do you want to ignore this user?
I have to agree with you on both points, except that I'm pretty sure we have that post position figured out.
Nostradawgus
How long do you want to ignore this user?
Hey Monk - I have seen some recent inter web chatter that maybe we don't have it figured out. Maybe push back on, well, pushing someone out. You heard anything recent?
Monkdawg
How long do you want to ignore this user?
No, I haven't heard that. I guess it's possible, but schollies are 1 year deals so.... I'm not sure technically that a player would have any valid complaint.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.